<scp>IgE</scp> levels in patients with atopic dermatitis steadily decrease during treatment with dupilumab regardless of dose interval-Reference-Cited by-同舟云学术

IgE levels in patients with atopic dermatitis steadily decrease during treatment with dupilumab regardless of dose interval

Published:2023-09-12 Issue:11 Volume:53 Page:1222-1225
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Experimental Allergy

Author:

Dekkers Coco¹²^ORCID,van der Wal M. Marlot²^ORCID,van den Noort Leonie²^ORCID,Bakker Daphne S.¹^ORCID,de Bruin‐Weller Marjolein¹^ORCID,van Wijk Femke²^ORCID

Affiliation:

1. National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology University Medical Center Utrecht Utrecht The Netherlands

2. Center for Translational Immunology University Medical Center Utrecht Utrecht The Netherlands

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.14384

Reference9 articles.

1. Dupilumab: A review of its use in the treatment of atopic dermatitis

2. Targeting key proximal drivers of type 2 inflammation in disease

3. Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre

4. Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-facio-cutaneous Syndrome with Severe Inflammatory Cutaneous Lesions: Dramatic Effect of Dupilumab;Acta Dermato-Venereologica;2024-09-05

2. Real‐world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years;Allergy;2024-08-07

3. Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels;Dermatology and Therapy;2024-07-27